Navigation Links
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
Date:4/22/2009

eams at the Center for Vaccine Development and the Naval Medical Research Center -- findings that were never translated into a vaccine development effort because the task was considered to be impossible."

Sanaria Inc. was founded in 2003. The company's primary mission is to develop and commercialize a malaria sporozoite vaccine against Plasmodium falciparum, the parasite responsible for more than 95 percent of malaria-associated severe illness and death world-wide, and the malaria parasite for which there is the most significant drug resistance. Sanaria has overcome the initial technological and regulatory barriers with support from many partners and colleagues, including those at the National Institute of Allergy and Infectious Diseases, the US Military Malaria Vaccine Program, the US Army Military Infectious Diseases Research Program, the Institute for One World Health, the PATH Malaria Vaccine Initiative, and the University of Maryland School of Medicine Center for Vaccine Development. Sanaria's facilities are in Rockville, MD. For more information, see www.sanaria.com.

Except for historical information, this news release contains certain forward-looking statements that involve known and unknown risk and uncertainties, which may cause actual results to differ materially from any future results, performance or achievements expressed or implied by the statements made. Such statements include the assessment of the vaccine candidate, expectations for the number and timing of the inoculation of study subjects, the expectations for immunity of the vaccine, and belief concerning the measure of success. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the Company's ability to raise sufficient fund
'/>"/>

SOURCE Sanaria Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
2. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
5. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
6. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
7. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
8. Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
9. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
10. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
11. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 GenSpera, Inc. ... the treatment of cancer, announces the recent publication of ... Steroids . The recent article co-authored ... the evolution and development of GenSpera,s prodrug technology platform that ... thapsigargin (from the plant Thapsia garganica ) directly ...
(Date:8/28/2014)... MONROVIA, Calif. , Aug. 28, 2014  STAAR Surgical ... and marketer of implantable lenses and delivery systems for the ... 2014 Health Care Conference at the New York Palace Hotel ... Barry Caldwell , President and CEO will ... financial results, and operational developments and be joined by ...
(Date:8/28/2014)... -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ... trials evaluating the use of collagenase clostridium histolyticum (CCH) for ... with a palpable cord will be presented at the upcoming ... Surgery of the Hand (ASSH) being held in ... (CCH) is a biologic approved in the U.S., EU, ...
Breaking Medicine Technology:GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3STAAR Surgical To Present At The Baird 2014 Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 6
(Date:8/28/2014)... Chicago, IL (PRWEB) August 28, 2014 ... Group, Inc., has been re-certified as a federal Patient ... authority of the Agency for Healthcare Research and Quality ... industry-leading patient safety expertise and services following the true ... (PSQIA) of 2005. , ”We are proud and eager ...
(Date:8/28/2014)... THURSDAY, Aug. 28, 2014 (HealthDay News) -- Having greater ... your ability to see distant objects in hazy conditions, ... University of Georgia researchers simulated hazy conditions in order ... levels of yellow pigment (also called macular pigment) in ... of yellow pigment, which represents accumulations of the nutrients ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 GreenRushReview.com, ... sector recently launched a “Video” section located at ... general information on various cannabis companies in video ... find an assortment of news clips, interviews, and ... announcements. A portion of the videos can also ...
(Date:8/28/2014)... On September 10, the Mesothelioma Applied Research ... president and CEO of Aduro BioTech, during a new ... live broadcast. The interview will be led by ... nurse practitioner, Mary Hesdorffer, APRN . , The ... therapy for malignant pleural mesothelioma, known as CRS-207. CRS-207 ...
(Date:8/28/2014)... August 28, 2014 PreDiabetes Centers, the ... of nutritious pizza recipes to help clients and online ... Day. PreDiabetes Concierge Chef Han Ashley developed variations of ... the Company’s website. , The PreDiabetes Centers Roasted Veggie ... pizza dough and features a cheese substitute–ideal for ...
Breaking Medicine News(10 mins):Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 2Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 3
... Partnership to Focus on Energy Conservation and Facility Retrofitting ... July 23 Health Care Without Harm (HCWH) has entered into ... the William J. Clinton Foundation, to develop programs to help hospitals ... of carbon reduction. HCWH will work with CCI to develop ...
... A study led by researchers at the Ohio State ... how late-stage, hormone-independent prostate tumors gain the ability to ... hormone-independent growth marks an advanced and currently incurable stage ... 24, 2009, issue of the journal Cell , ...
... release is available in German . , The ... often overestimated. According to the German Institute for Quality and Efficiency ... travellers. When people wear a cast or splint after a sports ... have an increased risk of deep vein thrombosis in their leg ...
... , SOUTH SAN FRANCISCO, Calif., July 23 ... Company plans to host a conference call on Thursday, July 23, 2009 ... management team and the principal investigator of the trial will discuss results ... arthritis, the Company,s plans for further development and related matters. , ...
... ... heart function without need for cardiac stem cells , ... (Vocus) July 16, 2009 -- Injured heart tissue normally can,t regrow, ... heart tissue after a heart attack, in patients with heart failure, or in children with ...
... how ,plastic, these non-embryonic cells can be, experts say ... may be named "Tiny," but what it represents in ... According to Chinese researchers, the birth of Tiny (and ... Healthy, fertile animals grown using so-called pluripotent stem cells ...
Cached Medicine News:Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 2Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 3Health News:Scientists discover key event in prostate cancer progression 2Health News:The risk of developing deep vein thrombosis during a flight is often overestimated 2Health News:Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 2Health News:Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 2Health News:Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 3Health News:Scientists Use Adult Stem Cells to Create Healthy Mice 2Health News:Scientists Use Adult Stem Cells to Create Healthy Mice 3
... Stabilization with the Orthofix Pelvic Fixator is ... into the pelvis, and a fixator assembly ... by a connector unit. A supplementary link ... in iliac crest applications. With this new ...
The Pinless Fixator can be applied quickly and easily in the OR or ER to stabilize the fracture and soft tissues without invading the medullary canal, minimizing the risk of infection associated with...
The Adjustable Large Fixator is a one-piece fixator with a radiolucent body. It has a multifunctional design pivoting pin clamp for use in ankle or tibial plateau fractures....
The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
Medicine Products: